Loading...
Loading...
JP Morgan has published a research report for Vitamin Shoppe, Inc.
VSI after meeting with VSI management.
In the report, JP Morgan writes "We had meetings with Vitamin Shoppe's CEO Rick Markee and CFO Michael Archbold in Chicago last Thursday (9/30). In our opinion, management sounded confident with respect to overall industry trends and the Vitamin Shoppe model – both in the near-term (next 12 months) and over the longer-term. Moreover, the company reiterated its plans to achieve 10% operating margins within the next 4 years (from ~7.0% today)."
JP Morgan maintains its Overweight rating but has raised the price target from $28 to $31.
Vitamin Shoppe Inc. closed yesterday at $28.18
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In: Analyst ColorPrice TargetAnalyst RatingsJP Morganmichael archboldrick markeevitamin shoppe
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in